Organisation paid for research Program year 2020 Source: CMS Open Payments

Beyer Research

Neither a doctor nor a teaching hospital

Research payments

$39,098

18 payments

Through program year 2020, Beyer Research is reported as receiving $39,098 in research payments, across 18 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$371	1
2019	Research	$38,727	17

Breakdown

Who paid Research payments · program years 2019–2020

Sebela Pharmaceuticals Inc. $29,913 10 payments
AMAG Pharmaceuticals, Inc. $7,757 4 payments
Allergan Inc. $1,427 4 payments

Studies the money was for Research payments · program years 2019–2020

A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability $29,913 10 payments
Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone $7,757 4 payments
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Treatment, 2-Stage, Dose Finding Study Evaluating the Efficacy and Safety of Botox Intravesical Installation in Participants With Overactive Bladder and Urinary Incontinence. $1,202 3 payments
A Multicenter, Randomized, Open Label Extension Study to Evaluate the Long Term Safety and Toloerability of Oral Ubrogepant in the Acute Treatment of Migraine With Or Without Aura $225 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.